TRU-016 and bendamustine
16201
Phase 2 small_molecule completed
Quick answer
TRU-016 and bendamustine for Chronic Lymphocytic Leukemia (CLL) is a Phase 2 program (small_molecule) at Aptevo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptevo Therapeutics
- Indication
- Chronic Lymphocytic Leukemia (CLL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed